Hans U Scherer

Summary

Affiliation: Humboldt University
Country: Germany

Publications

  1. ncbi [Biologicals in the treatment of rheumatic diseases]
    H U Scherer
    Klinik für Rheumatologie und Klinische Immunologie, Charite Universitatsmedizin Berlin
    Dtsch Med Wochenschr 131:2279-85. 2006
  2. doi A clinical perspective of rheumatoid arthritis
    Hans Ulrich Scherer
    Department of Rheumatology and Clinical Immunology, Charite University Medicine Berlin, Germany
    Eur J Immunol 39:2044-8. 2009
  3. doi Patient-tailored therapy in rheumatoid arthritis: an editorial review
    Hans U Scherer
    Department of Rheumatology and Clinical Immunology, Charite University Medicine Berlin, Germany
    Curr Opin Rheumatol 22:237-45. 2010
  4. ncbi [Rheumatology]
    H U Scherer
    Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie, Charite Universitatsmedizin Berlin, Germany
    Internist (Berl) 46:882-91. 2005
  5. ncbi Do we still miss the chance of effectively treating early rheumatoid arthritis? New answers from a new study
    S Kary
    Rheumatology (Oxford) 43:819-20. 2004
  6. ncbi [Polyarteritis nodosa - a "classical" case]
    H U Scherer
    Charite Universitatsmedizin Berlin, Abteilung für Rheumatologie und klinische Immunologie, Berlin, Germany
    Z Rheumatol 65:311-4. 2006
  7. pmc Targeting activated T cells: successful use of anti-CD25 monoclonal antibody basiliximab in a patient with systemic sclerosis
    H U Scherer
    Ann Rheum Dis 65:1245-7. 2006

Detail Information

Publications8

  1. ncbi [Biologicals in the treatment of rheumatic diseases]
    H U Scherer
    Klinik für Rheumatologie und Klinische Immunologie, Charite Universitatsmedizin Berlin
    Dtsch Med Wochenschr 131:2279-85. 2006
  2. doi A clinical perspective of rheumatoid arthritis
    Hans Ulrich Scherer
    Department of Rheumatology and Clinical Immunology, Charite University Medicine Berlin, Germany
    Eur J Immunol 39:2044-8. 2009
    ..Some of the novel pathogenetic aspects, however, already influence decision making in the clinic...
  3. doi Patient-tailored therapy in rheumatoid arthritis: an editorial review
    Hans U Scherer
    Department of Rheumatology and Clinical Immunology, Charite University Medicine Berlin, Germany
    Curr Opin Rheumatol 22:237-45. 2010
    ..Such personalized, patient-tailored therapy is still not a reality in rheumatology practice. However, several important steps have recently been made towards achievement of this important goal...
  4. ncbi [Rheumatology]
    H U Scherer
    Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie, Charite Universitatsmedizin Berlin, Germany
    Internist (Berl) 46:882-91. 2005
    ..The following article presents an overview of currently available biologic agents in rheumatology and a prospect of those to come...
  5. ncbi Do we still miss the chance of effectively treating early rheumatoid arthritis? New answers from a new study
    S Kary
    Rheumatology (Oxford) 43:819-20. 2004
  6. ncbi [Polyarteritis nodosa - a "classical" case]
    H U Scherer
    Charite Universitatsmedizin Berlin, Abteilung für Rheumatologie und klinische Immunologie, Berlin, Germany
    Z Rheumatol 65:311-4. 2006
    ..This case underlines the interdisciplinary character of the disease, challenging neurologists, dermatologists, rheumatologists and orthopedics alike...
  7. pmc Targeting activated T cells: successful use of anti-CD25 monoclonal antibody basiliximab in a patient with systemic sclerosis
    H U Scherer
    Ann Rheum Dis 65:1245-7. 2006